Uric Acid Stimulates PINK1/Parkin-Mediated Mitophagy via Nrf2/HO-1 Pathway to Protect Against Neuronal Apoptosis in Alzheimer’s Disease
Antioxidants & Redox Signaling · 2025
DOI: 10.1089/ars.2024.0837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2025. Verfasst von Qian Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Apoptosis, NF-E2-Related Factor 2, Neurons. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Aims
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder among the elderly. Uric acid (UA), the end product of purine metabolism, functions as a potent free radical scavenger and helps mitigate oxidative stress. Several epidemiological studies revealed that serum UA levels are negatively correlated with the risk of AD; however, the molecular mechanisms remain unclear. Notably, β-amyloid (Aβ) deposition is implicated in the disruption of mitophagy, leading to neuronal apoptosis. In this study, we aim to elucidate the link between UA and AD and explore the underlying mechanisms.
Results
We demonstrated that UA improved cognitive impairment in 5×FAD mice and reduced neuronal apoptosis both in vivo and in vitro . UA reversed the expression of phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1), p-Parkin S65 , parkin, microtubule-associated protein 1 light chain 3 II/I, and p62 proteins inhibited by Aβ treatment, alleviated Aβ induced mitochondrial dysfunction, and disturbed dynamics. We found that UA activated nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1(HO-1) signaling both in vivo and in vitro . Furthermore, ML385, a Nrf2-specific inhibitor, reversed the increase in mitochondrial membrane potential and mitophagy promoted by UA and increased neuronal apoptosis in HT22 cells. The antiapoptotic effects of UA in HT22 cells were prevented by treatment with small interfering RNAs targeting PINK1. Conclusions and Innovation: These data suggest that UA stimulates PINK1/parkin-mediated mitophagy reducing Aβ-induced neuronal apoptosis through the Nrf2/HO-1 pathway, which plays a neuroprotective role in AD. Our findings confirmed that UA effectively reduces neuronal damage and cognitive impairment, highlighting its potential clinical applications in the treatment of AD. Antioxid. Redox Signal. 43, 381–399.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
- Health Evaluation Center, Osaka Gyoumeikan Hospital, Osaka, Japan.
- Department of Diabetes, Endocrinology and Clinical Immunology, Hyogo College of Medicine, Nishinomiya, Japan.
ORCID-Profile: Qian Zhang, Jidong Cheng
Zitieren
APA
Zhang, Q., Xie, Chen, B., Yu, L., Chen, J., Yan, Y., Zhang, M., Wang, Q., Xi, Y., Yamamoto, T., Koyama, H., & Cheng, J. (2025). Uric Acid Stimulates PINK1/Parkin-Mediated Mitophagy via Nrf2/HO-1 Pathway to Protect Against Neuronal Apoptosis in Alzheimer’s Disease. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2024.0837
Vancouver
Zhang Q, Xie, Chen B, Yu L, Chen J, Yan Y, et al. Uric Acid Stimulates PINK1/Parkin-Mediated Mitophagy via Nrf2/HO-1 Pathway to Protect Against Neuronal Apoptosis in Alzheimer’s Disease. Antioxidants & Redox Signaling. 2025. doi:10.1089/ars.2024.0837
BibTeX
@article{Zhang2025,
author = {Zhang, Qian and Xie, De and Chen, Binyang and Yu, Linqian and Chen, Jiayu and Yan, Yunbo and Zhang, Mingyan and Wang, Qiang and Xi, Yuemei and Yamamoto, Tetsuya and Koyama, Hidenori and Cheng, Jidong},
title = {Uric Acid Stimulates PINK1/Parkin-Mediated Mitophagy via Nrf2/HO-1 Pathway to Protect Against Neuronal Apoptosis in Alzheimer’s Disease},
journal = {Antioxidants & Redox Signaling},
year = {2025},
doi = {10.1089/ars.2024.0837}
}
EUVIMED